RhumbLine Advisers
AFIB

RhumbLine Advisers’s Acutus Medical Inc AFIB Stock Holding History

RhumbLine Advisers’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,238
Closed -$17K – 3277
2022
Q1 		$17K Buy
12,238
+1,048
+9% +$2.24K ﹤0.01% 3003
2021
Q4 		$38K Buy
11,190
+100
+0.9% +$563 ﹤0.01% 2991
2021
Q3 		$98K Buy
11,090
+725
+7% +$9.54K ﹤0.01% 2997
2021
Q2 		$176K Buy
+10,365
New +$152K ﹤0.01% 2931
2021
Q1 		– Sell
-9,806
Closed -$283K – 3035
2020
Q4 		$283K Buy
9,806
+1,592
+19% +$43.1K ﹤0.01% 2697
2020
Q3 		$245K Buy
+8,214
New +$249K ﹤0.01% 2607

Other funds holding AFIB

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KSCM
Kamunting Street Capital Management Miami Beach, Florida $183M AUM 2.19% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return